# Alkaloid marked 10% growth in consolidated sales, 11% growth in consolidated net profit, investments of MKD 861.4 million and 143 new employments in the period January - December 2017

> „Alkaloid AD“ Skopje achieved positive financial results in the period January-December 2017 - shows the unaudited standalone and unaudited consolidated…

Source: https://alkaloid.com.mk/alkaloid-marked-10-percent-growth-in-consolidated-sales-in-the-period-january-december-2017

Feb 28, 2018

„Alkaloid AD“ Skopje achieved positive financial results in the period January-December 2017 - shows the unaudited standalone and unaudited consolidated Income Statement.

According to the unaudited standalone Income Statement, in the period January- December the sales reached the amount of MKD 6,932,176,270 - 8% up on the same period last year. Earnings before interest, taxes, depreciation and amortization (EBITDA), which amount to MKD 1,305,754,848 marked an increase of roughly 8%, whereas the net profit amounting to MKD 765,954,710 rose by 9%.

In the period January – December the total consolidated sales reached MKD 9,094,716,094 – an increase of 10% compared to the same period last year. Consolidated sales in the domestic market increased by 5%, while the total consolidated export of the company increased by 13%. Out of the total consolidated sales, 38% were realized in the domestic market, while the foreign markets account for 62%. The breakdown by region shows that the countries of South-East Europe account for 33% of the sales, Russia and CIS – 7%, 20% of the sales were realized in the countries from Western Europe (EU and EFTA), while the other markets account for 1% of the total consolidated sales. Noticeable rise was seen in Great Britain reaching sales of MKD 202,665,540 - increased by 13 times and Hungary with sales of MKD 31,452,936 – increased by 3.5 times compared to the same period last year. Growth in sales was also marked in the following export markets: Romania - 60%, Czech Republic - 22%, Poland - 65%, Slovenia - 12%, Croatia - 13%, Russia - 17%, Ukraine - 208% etc.

The breakdown of total consolidated sales by group of products shows that the best sellers are the products from the segment Pharmaceuticals – 85%, with OTC products accounting for 21%, cardiovascular products - 16%, antibiotics - 14%, neurological products – 13% etc. The Chemistry Cosmetics Botanicals segment accounts for 15% of the total consolidated sales, or more precisely Chemistry – 3%, Cosmetics – 9% and Botanicals – 3%.

Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA), which reached MKD 1,413,336,067 saw an increase of 9%, whereas the net consolidated profit amounting to MKD 809,277,171 went up by 11%.

The total investments in non-current assets for the period January – December 2017 amounted to MKD 861,420,437.

In the period January – December 2017 Alkaloid recruited 143 new employees in the Republic of Macedonia.

Oct 29, 2026[ALKALOID – Operating Results for the January – September 2026 period](https://alkaloid.com.mk/alkaloid-operating-results-for-the-january-september-2026-period)

* * *

Oct 28, 2026[ALKALOID BECOMES THE FIRST COMPANY IN MACEDONIA TO RECEIVE THE PRESTIGIOUS TOP EMPLOYER 2026 CERTIFICATION](https://alkaloid.com.mk/alkaloid-top-employer-2026)

* * *

Oct 8, 2026[ALKALOID MARKS ITS 23RD PARTICIPATION IN CPHI, THE WORLD’S LEADING PHARMACEUTICAL EVENT](https://alkaloid.com.mk/alkaloid-marks-its-23-rd-participation-in-cphi-the-world-s-leading-pharmaceutical-event)

* * *

Sep 22, 2026[MUKAETOV AT THE 25TH MACEDONIAN STOCK EXCHANGE CONFERENCE: SMALL MARKET, BIG OPPORTUNITY](https://alkaloid.com.mk/mukaetov-at-the-25th-macedonian-stock-exchange-conference)

* * *

Sep 21, 2026[FROM ATOP A FACTORY CHIMNEY TO AN ART INSTALLATION: THE STORY OF ALKALOID’S HISTORIC SIGN](https://alkaloid.com.mk/from-atop-a-factory-chimney-to-an-art-installation-the-story-of-alkaloid-s-historic-sign)

* * *